Currently out of the existing stock ratings of Scott Schoenhaus, 65 are a BUY (91.55%), 6 are a HOLD (8.45%).

Scott Schoenhaus

Work Performance Price Targets & Ratings Chart

Analyst Scott Schoenhaus works at KEYBANK with a stock forecast success ratio of 40.79% fulfilled within 41.88 days on average. Previously, Scott Schoenhaus worked at STEPHENS.

Scott Schoenhaus’s has documented 135 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on ABSI, Absci Corp at 04-Mar-2024.

Wall Street Analyst Scott Schoenhaus

Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for RXRX (RECURSION PHARMACEUTICALS) at 7/13/2023. The price target of $15 was fulfilled within 6 days with a profit of $2.56 (20.58%) receiving and performance score of 34.3.

Average potential price target upside

of $34.14 (16.59%) on VEEV (VEEVA SYSTEMS).
of $22.35 (10.56%) on TDOC (TELADOC).
of $21.25 (10.83%) on IQV (IQVIA HOLDINGS).

TDOC Teladoc VCRA Vocera Communications VEEV Veeva Systems IQV IQVIA Holdings OMCL Omnicell ALIT Alight GDRX Goodrx Holdings HQY HealthEquity RCM R1 RCM BNFT Benefitfocus PGNY Progyny PHR Phreesia RXRX Recursion Pharmaceuticals HCAT Health Catalyst ABCL Abcellera Biologics ABSI Absci Corp SDGR Schrodinger

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ryan Macdonald (NEEDHAM)